Clinical Trial Update: A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2) [Phase 3]

View source ↗

Summary

Phase 3 clinical trial (STYLE 2) evaluating dupilumab versus placebo for pruritus in adults with lichen simplex chronicus; status is active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lichen Simplex Chronicus

Drugs mentioned

• Dupilumab (Dupixent) (Dupilumab)

Snippet

Sponsor: Sanofi | Conditions: Lichen Simplex Chronicus | Phase 3 | Status: ACTIVE_NOT_RECRUITING